IJCM  Vol.8 No.12 , December 2017
Solasodine, Solamargine and Mixtures of Solasodine Rhamnosides: Pathway to Expansive Clinical Anticancer Therapies
Abstract: Cancer remains a major cause of mortality worldwide. Progresses have been made in the understanding of the molecular basis of cancer, cancer detection, and cancer treatment. Important strides by treating early-stage cancers have resulted in improved outcomes. Despite these achievements, mortality of cancer patients is high and still there is no cure. Some oncologists remain optimistic that cytotoxic chemotherapy will significantly improve cancer survival. However, notwithstanding the use of new and expensive single and more recently, combination drugs, the improvement of the response rates remains very low. In the United States, cancer death rates decreased by a mere 1.4% to 1.8% from 2004 to 2013. Compared to other serious diseases, the improvement of the cancer patient has been disappointingly lagging, and by far, most patients with advanced cancer eventually die of their disease. The need for improved cancer therapies is self-evident. This communication gives an overview of the overwhelming resurgence of solasodine and its glycosides in cancer therapy.
Cite this paper: Cham, B. (2017) Solasodine, Solamargine and Mixtures of Solasodine Rhamnosides: Pathway to Expansive Clinical Anticancer Therapies. International Journal of Clinical Medicine, 8, 692-713. doi: 10.4236/ijcm.2017.812064.

[1]   Cham, B.E. and Wilson, L. (1987) HPLC of Glycoalkaloids from Solanum sodomaeum. Planta Medica, 53, 59-62.

[2]   Daunter, B. and Cham, B.E. (1990) Solasodine Glycosides. In Vitro Preferential Cytotoxicity for Human Cancer Cells. Cancer Letters, 55, 209-220.

[3]   Cham, B.E., Gilliver, M. and Wilson, L. (1987) Antitumor Effects of Glycoalkaloids Isolated from Solanum sodomaeum. Planta Medica, 53, 34-36.

[4]   Cham, B.E. and Meares, H.M. (1987) Glycoalkaloids from Solanum sodomaeum Are Effective in the Treatment of Skin Cancers in Man. Cancer Letters, 36, 111-118.

[5]   Cham, B.E. and Daunter, B. (1990) Topical Treatment of Pre-Malignant and Malignant Skin Cancers with Curaderm. Drugs of Today, 26, 55-58.

[6]   Cham, B.E. (2013) Inspired by Nature, Proven by Science. The New Generation Cancer Treatment That Causes Cancer Cells to Commit Suicide. Colorite Graphics Printers, Port Vila, 264 p.

[7]   AlSinani, S.S., Eltayeb, E.A., Coomber, B.L. and Adham, S.A. (2016) Solamargine Triggers Cellular Necrosis Selectively in Different Types of Human Melanoma Cancer Cells through Extrinsic Lysosomal Mitochondrial Death Pathways. Cancer Cell International, 16, 287-294.

[8]   Hu, K., Kobayashi, H., Dong, A., Jing, Y., Iwasaki, S. and Yao, X. (1999) Antineoplastic Agents III: Steroidal Glycosides from Solanum nigrum. Planta Medica, 65, 35-38.

[9]   Cham, B.E. (2013) Drug Therapy: Solamargine and Other Solasodine Rhamnosyl Glycosides as Anticancer Agents. Modern Chemotherapy, 2, 33-49.

[10]   Cham, B.E. (1994) Solasodine Glycosides as Anti-Cancer Agents: Pre-Clinical and Clinical Studies. Asia Pacific Journal of Pharmacology, 9, 113-118.

[11]   Vijayan, P., Vinod, K.S., Dhanaraj, S.A., Badami, S. and Suresh, B. (2002) In Vitro Cytotoxicity and Anti-Tumorproperties of the Total Alkaloid Fraction of Unripe Fruits of Solanum pseudocapsicum. Pharmacology Biology, 40, 456-460.

[12]   Ono, M., Nishimura, K., Suzuki, K., Fukushima, T., Igoshi, K., Yoshimitsu, H., Ikeda, T. and Nohara, T. (2006) Steroidal glycosides from the underground parts of Solanum sodomaeum. Chemical and Pharmaceutical Bulletin, 54, 230-233.

[13]   Nakamura, T., Komori, C., Lee, Y., Hashinoto, F., Yahara, S., Nohara, T. and Ejina, A. (1996) Cytotoxic Activities of Solanum Steroidal Glycosides. Biological and Pharmaceutical Bulletin, 19, 564-566.

[14]   Liu, L.F., Liang, C.H., Shiu, L.Y., Lin, W.L., Lin, C.C. and Kuo, K.W. (2004) Action of Solamargine on Human Lung Cancer Cells-Enhancement of the Susceptibility of Cancer Cells to TNFs. The FEBS Letters, 577, 67-74.

[15]   Lee, K.R., Kozukue, N., Han, J.S., Park, J.H., Chang, E.Y., Back, E.J., Chang, J.D. and Friedman, M. (2004) Glycoalkaloids and Metabolites Inhibit the Growth of Human Colon (HT29) and Liver (HepG2) Cancer Cells. Journal of Agricultural and Food Chemistry, 52, 2832-2839.

[16]   Kuo, K.W., Hsu, S.H., Li, Y.P., Lin, W.L., Liu, L.F., Chang, L.C., Lin, C.N., Lin, C.C. and Sheu, H.M. (2000) Anticancer Activity Evaluation of the Solanum Glycoalkaloid Solamargine. Triggering Apoptosis in Human Hepatoma Cells. Biochemical Pharmacology, 60, 865-1873.

[17]   Chang, L.C., Tsai, T.R., Wang, J.J., Lin, C.N. and Kuo, K.W. (1998) The Rhamnose Moiety of Solamargine Plays a Crucial Role in Triggering Cell Death by Apoptosis. Biochemical and Biophysical Research Communications, 242, 21-25.

[18]   Badami, S., Manohara Reddy, S.A., Kumar, E.P., Vijayan, P. and Suresh, B. (2003) Antitumor Activity of Total Alkaloid Fraction of Solanum pseudocapsicum Leaves. Phytotherapy Research, 17, 1001-1004.

[19]   Esteves-Souza, A., Sarmento da Silva, T., A loes, C.C.F., Carvalho, M., Braz-Filho, R. and Echevarria, A. (2002) Cytotoxic Activities against Ehrlich Carcinoma, Human K562 Leukaemia of Alkaloids and Flavonoids from Two Solanum Species. Journal of the Brazilian Chemical Society, 13, 838-842.

[20]   Chataing, B., Christancho, N.B. and Usubillaga, A. (1998) Topical Treatment of Herpes Simplex, Herpes Zoster and Genital Herpes with a Mixture of Solanaceous Glycoalkaloids. MedULA, 7, 30-34.

[21]   Chami, L.A., Méndez, R.B., Chataing, J., O’Callaghan, A., Usubillaga, A. and LaCruz, L. (2003) Toxicological Effects of α-Solamargine in Experimental Animals. Phytotherapy Research, 17, 254-258.

[22]   Hall, C.A., Hobby, T. and Cipollini, M. (2006) Efficacy and Mechanisms of α-Solasonine- and α-Solamargine-Induced Cytolysis on Two Strains of Trypanosoma cruzi. Journal of Chemical Ecology, 32, 2405-2416.

[23]   Verpoorte, R. (1998) Exploration of Nature’s Chemodiversity: The Role of Secondary Metabolites as Leads in Drug Development. Drug Discovery Today, 3, 232-238.

[24]   Roddick, J.G., Ryrenber, A.L. and Weissenber, M. (1990) Membrane-Disrupting Properties of the Steroidal Glycoalkaloids Solasonine and Solamargine. Phytochemistry, 29, 1513-1518.

[25]   Munari, C.C., de Oliveira, P.F., Campos, J.C.L., Martins, S.P.L., Da Costa, J.C., Bastos, J.K. and Tavares, D.C. (2014) Antiproliferative Activity of Solanum lycocarpum Alkaloidal Extract and Their Constituents, Solamargine and Solasonine, in Tumor Cell Lines. Journal of Natural Medicines, 68, 236-241.

[26]   Xu, X.H., Zhang, L., Wu, G.S., Chen, X., Li, T., Chen, X., Wang, Y.T. and Lu, J.J. (2017) Solasodine Induces Apoptosis, Affects Autophagy, and Attenuates Metastasis in Ovarian Cancer Cells. Planta Medica, 83, 254-260.

[27]   Yu, S., Sheu, H.M. and Lee, C.H. (2017) Solanum incanum Extract (SR-T100) Induces Melanoma Cell Apoptosis and Inhibits Established Lung Metastasis. Oncotarget, 8, 103509-103517.

[28]   Lipscombe, R.J., Carter, S.J. and Ruane, M. (2005) Rhamnose Binding Protein. US Patent No. 6930171.

[29]   Cham, B.E. and Daunter, B. (1990) Solasodine Glycosides. Selective Cytotoxicity for Cancer Cells and Inhibition of Cytotoxicity by Rhamnose in Mice with Sarcoma 180. Cancer Letters, 55, 221-225.

[30]   Wang, Y., Gao, J., Gu, G., Li, G., Cui, C., Sun., B. and Hongxiang, L. (2011) In Situ RBL Receptor Visualization and Its Mediated Anticancer Activity for Solasodine Rhamnosides. ChemBioChem, 12, 2418-2420.

[31]   Cham, B.E. (2000) Medicinal Compositions and Their Method of Preparation. Patent No. WO 00/61153.

[32]   Cham, A., Cham, K., Chase T. and Cham, B.E. (2015) A Standardized Plant Extract Containing a Target Compound Is Acceptable as a Potent Therapeutic Entity: Relevance to BEC and Solamargine, A Topical Clinical Formulation CuradermBEC5. Journal of Cancer Treatment and Research, 3, 22-27.

[33]   Shen, K.H., Hung, J.H., Chang, C.W., Weng, Y.T., Wu, M.J. and Chen, P.S. (2017) Solasodine Inhibits Invasion of Human Lung Cancer Cell through Downregulation of miR-21 and MMP Expression. Chemico-Biological Interactions, 268, 129-135.

[34]   Zhuang, Y., Wu, C., Zhou, J., Chen, X., Wu, J., Jiang, S., Peng, H., Zou, X., Liu, J., Gong, T., Qi, M., Xue, T., Liu, S. and Cai, H. (2017) Solasodine Inhibits Human Colorectal Cancer Cells through Suppression of AKT/Glycogen Synthase Kinase-3β/ β-Catenin Pathway. Cancer Science, 108, 2248-2264.

[35]   Koduru, S., Grierson, D.S., Venter, M. and Afolayan, A.J. (2007) Anticancer Activity of Steroidalkaloids Isolated from Solanum aculeastrum. Pharmaceutical Biology, 45, 613-618.

[36]   Jayakumar, K. and Murugan, K. (2017) Purified Solasodine and Caulophyllumine: A from Solanum mauritianum Scop. against MCF-7 Breast Cancer Cell Lines in Terms of Cell Growth, Cell Cycle and Apoptosis. Journal of Pharmacognosy and Phytochemistry, 6, 472-478.

[37]   Hameed, A., Ijaz, S., Mohammad, I.S., Muhammad, K.S., Akhtar, N. and Khan, H.M.S. (2017) Aglycone Solanidine and Solasodine Derivatives: A Natural Approach towards Cancer. Biomedicine & Pharmacotherapy, 94, 446-457.

[38]   Xie, X., Zhu, H., Yang, H., Huang, W., Wu, Y., Wang, Y., Luo, Y., Wang, D. and Shao, G. (2015) Solamargine Triggers Hepatoma Cell Death through Apoptosis. Oncology Letters, 10, 168-174.

[39]   Shiu, L.Y., Liang, C.H., Chang, L.C., Sheu, H.M., Tsai, E.M. and Kuo, K.W. (2009) Solamargine Induces Apoptosis and Enhances Susceptibility to Trastuzumab and Epirubicin in Breast Cancer Cells with Low or High Expression Levels of HER2/neu. Bioscience Reports, 29, 35-45.

[40]   Li, X., Zhao, Y., Wu, W.K., Liu, S., Cui, M. and Lou, H. (2011) Solamargine Induces Apoptosis with p53 Transcription-Dependent and Transcription-Independent Pathways in Human Osteosarcoma U2OS Cells. Life Sciences, 88, 314-321.

[41]   Shiu, L.Y., Chang, L.C., Liang, C.H., Huang, Y.S., Sheu, H.M. and Kuo, K.W. (2007) Solamargine Induces Apoptosis and Sensitizes Breast Cancer Cells to Cisplatin. Food and Chemical Toxicology, 45, 2155-2164.

[42]   Zhou, Y., Tang, Q., Zhao, S., Zhang, F., Li, l., Wu, W., Wang, Z. and Hann, S. (2014) Targeting Signal Transducer and Activator of Transcription 3 Contributes to the Solamargine-Inhibited Growth and -Induced Apoptosis of Human Lung Cancer Cells. Tumor Biology, 35, 8169-8178.

[43]   Punjabi, S., Cook, I., Kersey, P., Marks, R., Finlay, A., Sharpe, G. and Cerio, R. (2000) A Double Blind, Multi-Centre Parallel Group Study of BEC-5 Cream in Basal Cell Carcinoma. J Eu Acad Dermatol Venerol,14, 47-60.

[44]   Tambuscio, A., Siliprandi, L., Dario, M., Cham, A., Cham, B. and Bordignon, M. (2016) Treatment of Cutaneous Carcinomas with a Topical Cream Containing Solasodine Rhamnosides: Focus on Efficacy, Compliance and Cosmetic Outcomes. European Academy of Dermatology and Venereology Congress, Athens, May 2016, 19-22.

[45]   Cham, B.E., Daunter, B. and Evans, R. (1991) Topical Treatment of Malignant and Premalignant Skin Lesions by Very Low Concentrations of a Standard Mixture (BEC) of Solasodine Glycosides. Cancer Letters, 59, 183-192.

[46]   Cham, B.E. (2007) The Eggplant Cancer Cure: A Treatment for Skin Cancers and New Hope for Other Cancers from Nature’s Pharmacy. Smart Publications, Petalum.

[47]   Cham, B.E. (2007) Solasodine Rhamnosyl GlycosidesSpecifically Bind Cancer Cell Receptors and Induce Apoptosis and Necrosis. Treatment for Skin Cancer and Hope for Internal Cancers. Research Journal of Biological Sciences, 2, 503-514.

[48]   Cham, B.E. (2007) Solasodine Rhamnosyl Glycosides in a Cream Formulation Is Effective for Treating Large and Troublesome Skin Cancers. Research Journal of Biological Sciences, 2, 749-761.

[49]   Cham, B.E. (2008) Cancer Intralesion Chemotherapy with Solasodine Rhamnosyl Glycosides. Research Journal of Biological Sciences, 3, 1008-1017.

[50]   Cham, B.E. (2009) When Does Alternative Become Orthodox? Skin Cancer Treatment with Solasodine Rhamnosyl Glycosides in Its Transitional Stage, a Case Study. Evidence-Based Complementary and Alternative Medicine, 6, 415-420.

[51]   Cham, B.E. (2011) Topical Solasodine Rhamnosyl Glycosides Derived from the Eggplant Treats Large Skin Cancers: Two Case Reports. International Journal of Clinical Medicine, 2, 473-477.

[52]   Chase T.R. (2011) CuradermBEC5 for Skin Cancers, Is It? An Overview. Journal of Cancer Therapy, 2, 728-745.

[53]   Cham, B.E. (2012) Intralesion and Curaderm BEC Topical Combination Therapies of Solasodine Rhamnosyl Glycosides Derived from the Eggplant or Devil’s Apple Result in Rapid Removal of Large Skin Cancers. Methods of Treatment Compared. International Journal of Clinical Medicine, 3, 115-124.

[54]   Cham, B.E. (2013) Topical CuradermBEC5 Therapy for Periocular Nonmelanoma Skin Cancer: A Review of Clinical Outcomes. International Journal of Clinical Medicine, 4, 233-238.

[55]   Cham, B.E. (2013) Solasodine Glycosides: A Topical Therapy for Actinic Keratosis. A Single-Blind, Randomized, Placebo-Controlled, Parallel Group Study with CuradermBEC5. Journal of Cancer Therapy, 4, 588-596.

[56]   Cham, B.E. (2014) A Review of Solasodine Rhamnosides Therapy for In-Situ Squamous Cell Carcinoma on the Penis. British Journal of Medicine and Medical Research, 4, 621-631.

[57]   Cham, A. and Cham, B.E. (2015) Treatment of Skin Cancer with a Selective Apoptotic-Inducing CuradermBEC5 Topical Cream Containing Solasodine Rhamnosides. International Journal of Clinical Medicine, 6, 326-333.

[58]   Cham, B.E., Cham, K., Cham, A., Chase, T. and Zhou, V. (2015) Treatment of Non Melanoma Skin Cancers: An Intra-Comparison Study of CuradermBEC5 and Various Established Modalities. Journal of Cancer Therapy, 6, 1045-1053.

[59]   Batsev, A.F., Dobrokhotova, V.Z. and Cham, B.E. (2016) Topical Cream CuradermBEC5 Treats a Recalcitrant Basal Cell Carcinoma. Clinical Medical Reviews and Case Reports, 3, Article No. 098.

[60]   Goldberg, L.H., Landau, J.M., Moody, M.N. and Vergilis-Kalner, I.J. (2011) Treatment of Bowen’s Disease on the Penis with Low Concentrations of a Standard Mixture of Solasodine Glycosides and Liquid Nitrogen. Dermatologic Surgery, 37, 858-861.

[61]   Punjabi, S., Cook, L.J., Kersey, P., Marks, R. and Cerio, R. (2008) Solasodine Glycoalkaloids: A Novel Topical Therapy for Basal Cell Carcinoma. A Double Blind, Randomized, Placebo-Controlled, Parallel Group, Multicentre Study. International Journal of Dermatology, 47, 78-82.

[62]   Bordingnon, M. (2016) Efficacy and Safety of CuradermBEC5 in the Treatment of Basal Cell Carcinoma: A Pilot Study in the Italian Population. European Academy of Dermatology and Venereology Congress, Athens.

[63]   Dobrokhotova, F.Z., Betsev, A.F. and Belysheva, T.S. (2016) The Use of Kuraderm Drug in the Treatment of Basal Cell Carcinoma of the Head and Neck. Head and Neck Tumors, 6, 22-26.

[64]   Li, X., Zhao, Y., Liu, S., Cui, M. and Lou, H. (2011) Induction of Actin Disruption and Downregulation of P-Glycoprotein Expression of Solamargine in Multidrug-Resistant K562/A02 Cells. Chinese Medical Journal, 124, 2038-2044.

[65]   Friedman, M. (2015) Chemistry and Anticarcinogenic Mechanisms of Glycoalkaloids Produced by Eggplants, Potatoes and Tomatoes. Journal of Agricultural and Food Chemistry, 63, 3323-3337.

[66]   Jiang, Q., Chen, M., Cheng, K., Yu, P., Wei, X. and Shi, Z. (2016) Therapeutic Potential of Steroidal Alkaloids in Cancer and Other Diseases. Medicinal Research Reviews, 36, 119-143.

[67]   Kessenbrock, K., Plaks, V. and Werb, Z. (2010) Matrix Metalloproteinases: Regulators of the Tumor Microenvironment. Cell, 141, 52-67.

[68]   Sani, I.K., Marashi, S.H. and Kalalinia, F. (2015) Solamargine Inhibits Migration and Invasion of Human Hepatocellular Carcinoma Cells through Down-Regulation of Matrix Metalloproteinases 2 and 9 Expression and Activity. Toxicology in Vitro, 29, 893-900.

[69]   Cham, B.E. and Chase, T.R. (2012) Solasodine Rhamnosyl Glycosides Cause Apoptosis in Cancer Cells. Do They Also Prime the Immune System Resulting in Long Term Protection against Cancer? Planta Medica, 78, 349-353.

[70]   Van der Most, R.G., Himbeck, R., Aarons, S., Carter, S.J., Larma, I., Robinson, C., Currie, A. and Lake, R.A. (2006) Antitumor Efficacy of the Novel Chemotherapeutic Agent Coramsine Is Potentiated by Cotreatment with CpG-Containing Oligodeoxynucleotides. Journal of Immunotherapy, 29, 134-142.

[71]   Chataing, B., Concepcion, J.L., Buitrago de Cristancho, N. and Usubillaga, A. (2001) Clinical Study of the Effectiveness of Extracts Alkaloids Obtained of the Fruits of Solanum americanum Miller on Herpes Simplex, Herpes Two Zoster and Genital Herpes. MedULA, 7, 30-35.

[72]   Thorne, H.V., Clarke, G.F. and Skuce, R. (1985) The Inactivation of Herpes Simplex Virus by Some Solanaceae Glycoalkaloids. Antiviral Research, 5, 335-343.

[73]   Basu, A. and Lahiri, S.C. (1977) Some Pharmacological Actions of Solasonine. Indian Journal of Experimental Biology, 15, 85-289.

[74]   SolbecPharmaceut (2005) Pre-IND Submission 5.

[75]   Friedman, M., Henika, P.R. and Mackay, B.E. (1996) Feeding of Potato, Tomato and Eggplant Alkaloids Affects Food Consumption and Body and Liver Weights in Mice. Journal of Nutrition, 126, 989-999.

[76]   Xiang, S.T., Zhang, Q.H., Tang, Q., Zheng, F., Wu, J.J., Yang, L.J. and Hann, S.S. (2016) Activation of AMPKα Mediates Additive Effects of Solamargine and Metformin on Suppressing MUC 1 Expression in Castration-Resistant Prostate Cancer Cells. Scientific Reports, 6, Article No. 36721.

[77]   Keeler, R.F., Baker, D.C. and Gaffield, W. (1990) Spirosolane-Containing Solanum Species and Induction of Congenital Craniofacial Malformations. Toxicon, 28, 873-884.

[78]   Zeng, X., Xu, L., Liang, Y., Xiao, W., Xie, L., Zhang, Y., Zhao, L., Cao, L., Chen, J. and Wang, G. (2011) Quantitative Determination and Pharmacokinetic Study of Solamargine in Rat Plasma by Liquid Chromatography—Mass Spectrometry. Journal of Pharmaceutical and Biomedical Analysis, 55, 1157-1162.

[79]   Millward, M., Powell, A., Daly, P., Tyson, S., Ferguson, R. and Carter, S. (2006) Results of Phase 1 Clinical Trials of Coramsine in Patients with Advanced Solid Tumors. Journal of Clinical Oncology, 24, 2070.